RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

The fund owned 9,662 shares of the pharmacy operator’s stock after selling ... A number of research analysts have recently ...

CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising ...

Amazon is winning the U.S. price wars, leaving Walmart and Target behind for the eighth consecutive year. The e-commerce ...

Prem Shah, who joined the company in 2013, will lead CVS Caremark, CVS Pharmacy, and the company’s Health Care Delivery ...

The pharmacy operator reported $1.09 EPS for the quarter ... Mizuho decreased their price target on CVS Health from $73.00 to ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...

One pharmacy is eating the next one ... and they're not making the money they thought they were. And when CVS took over Target’s pharmacies, techs were pissed because they got away from CVS ...

The CVS Pharmacy located at 6920 Laurel-Bowie Road, inside the Bowie Plaza shopping mall is scheduled to close on Tues., Dec. 3.